Next Generation Sequencing Kits Markets, 2035 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Next Generation Sequencing Kits Market: Distribution by Type of Nucleotide Sequenced, Type of End User and Key Geographies – Industry Trends and Global Forecasts, 2022-2035” report has been added to ResearchAndMarkets.com’s offering.

The “Next Generation Sequencing (NGS) Kits Market” report features an extensive study of the current market landscape and future potential of NGS library preparation kits over the next decade. The study features an in-depth analysis of the key drivers and trends related to this domain.

One of the key objectives of the report was to estimate the existing market size and identify potential growth opportunities for NGS library preparation kits over the coming decade. We have provided an informed estimate on the likely evolution of the market over the period 2021-2035.

Compared to the Human Genome Project (~USD 3 billion), the cost of sequencing a single genome has decreased considerably (to USD 1,000), for currently available technologies. Given the ongoing innovation in this field, stakeholders further believe that, over the next decade, the aforementioned cost may further get reduced to USD 100. It is worth mentioning that this decrease in genome sequencing cost has led to an increase in the number of genomes being sequenced, across the globe.

Despite the recent advances in the field of genomics, the nucleotide library preparation process is still marred with several challenges, including requirement of large amounts of input samples, low volume of yield and concerns related to quality of the product.

In addition, the manual DNA library / RNA library preparation process is time consuming, requiring extensive manipulation and expensive reagents. Therefore, innovators in the pharmaceutical industry are constantly identifying / developing ways to improve the process of DNA library / RNA library preparation.

Amidst other alternatives, the use of NGS library preparation kits has emerged as a viable option for various drug developers and academic / research institutes to overcome the existing challenges associated with conventional DNA library / RNA library preparation methods. These kits require less input material and are capable of generating precise DNA library / RNA libraries with minimum errors.

Presently, more than 280 NGS library preparation kits are available in the market; these are compatible with a broad range of sequencing platforms, including Illumina, Ion Torrent and BGI NGS platforms. It is worth mentioning that over 3,200 patents related to NGS library preparation kits have been filed / granted in the past few years, demonstrating the continued innovation in this domain. Driven by the increasing demand for gene therapies and the introduction of novel and advanced NGS techniques, the NGS library preparation kits market is anticipated to witness steady growth in the coming years.

Key Topics Covered:

1. PREFACE

1.1. Scope of the Report

1.2. Research Methodology

1.3. Key Questions Answered

1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

3.1. Chapter Overview

3.2. Overview of Genome Sequencing

3.3. Types of Genome Sequencing

3.4. Future Perspectives

4. MARKET LANDSCAPE

4.1. Chapter Overview

4.2. Next Generation Sequencing Kits: Overall Market Landscape

4.3. Next Generation Sequencing Kits: List of Providers

5. PRODUCT COMPETITIVENESS ANALYSIS

5.1. Chapter Overview

5.2. Assumptions and Methodology

5.3. Product Competitiveness Analysis: Competitive Landscape

6. COMPANY PROFILES: NEXT GENERATION SEQUENCING KITS PROVIDERS IN NORTH AMERICA

6.1. Chapter Overview

6.2. Agilent Technologies

6.3. BioDynami

6.4. Creative Biogene

6.5. New England Biolabs

6.6. PerkinElmer

6.7. Thermo Fisher Scientific

7. COMPANY PROFILES: NEXT GENERATION SEQUENCING KITS PROVIDERS IN EUROPE

7.1. Chapter Overview

7.2. Abcam

7.3. Devyser

7.4. Diagenode

7.5. Lexogen

7.6. Roche

7.7. Tecan

8. COMPANY PROFILES: NEXT GENERATION SEQUENCING KITS PROVIDERS IN ASIA PACIFIC

8.1. Chapter Overview

8.2. Enzynomics

8.3. MGI

8.4. Takara Bio

8.5. TIANGEN Biotech

8.6. TransGen Biotech

8.7. Vazyme

9. PATENT ANALYSIS

9.1. Chapter Overview

9.2. Scope and Methodology

9.3. Next Generation Sequencing Kits: Patent Analysis

9.4. Next Generation Sequencing Kits: Patent Benchmarking

9.5. Next Generation Sequencing Kits: Patent Valuation

9.6. Leading Patents: Analysis by Number of Citations

10. MARKET FORECAST AND OPPORTUNITY ANALYSIS

10.1. Chapter Overview

10.2. Forecast Methodology and Key Assumptions

10.3. Global Next Generation Sequencing Kits Market, 2021-2035

10.3.1. Next Generation Sequencing Kits Market, 2021 and 2035: Distribution by Type of Nucleotide Sequenced

10.3.2. Next Generation Sequencing Kits Market, 2021 and 2035: Distribution by Type of End User

10.3.3. Next Generation Sequencing Kits Market, 2021 and 2035: Distribution by Geography

11. CASE STUDY: NEXT GENERATION SEQUENCING TECHNOLOGIES AND SERVICE PROVIDERS

11.1. Chapter Overview

11.2. Historical Evolution of Genome Sequencing

11.3. Next Generation Sequencing Technologies

11.4. Next Generation Sequencing Service Providers

11.5. Next Generation Sequencing Service Providers: Non-Industry Players

12. CONCLUDING REMARKS

13. EXECUTIVE INSIGHTS

13.1. Chapter Overview

13.2. Tecan

14. APPENDIX 1: TABULATED DATA

15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

Companies Mentioned

• 10x Genomics
• 1st BASE
• Abcam
• ABclonal
• Advanced Biological Laboratories (ABL)
• Active Motif
• Admera Health
• Agendia
• Agilent Technologies
• Agiomix
• AgriGenome Labs
• Almac Group
• Annoroad Gene Technology
• ANTISEL
• Applied Biological Materials (abm)
• Arizona Genomics Institute
• Auragen
• Australian Genome Research Facility (AGRF)
• BD
• BGI Genomics
• BioChain
• BioDynami
• Biofidal
• Bio-Rad
• Biosearch Technologies (Acquired by LGC)
• Brigham and Women’s Hospital
• Brigham Young University
• Broad Institute
• CD Genomics
• CeGaT
• Cellecta
• CEN4GEN
• CENTOGENE
• Centre for Cellular and Molecular Platforms (C-CAMP)
• Children’s Hospital of Philadelphia
• City of Hope
• Claret Bioscience
• Cold Spring Harbor Laboratory
• Columbia Genome Center
• Creative Biogene
• Dana-Farber Cancer Institute
• Dante Labs
• De Novo Genomics
• Devyser
• DiaCarta
• Diagenode (Acquired by Hologic)
• Diagnomics
• Diversigen
• DNA Genotek
• DNA Link
• DNAVision
• Durham University
• Earlham Institute
• Eclipse Bioinnovations
• Edinburgh Genomics
• Enzo Life Sciences
• Enzynomics
• EpiGentek
• Eurofins Genomics
• Fasteris
• Firalis
• Fluidigm
• Fulgent Genetics
• Full Genomes Corporation (FGC)
• Garvan Institute of Medical Research
• Genapsys
• Gencove
• Gene by Gene
• GeneFirst
• GENEWIZ
• Genome.One
• GenomeScan
• GenomeStream
• Genomics Personalized Health
• Genomix4Life
• Genosity
• Genotypic Technology
• GenScript
• Genuity Science (Previously known as WuXi NextCODE)
• GenXPro
• Guardant Health
• Harvard College
• HistoGenetics
• Icahn Institute for Data Science and Genomic Technology
• Integrated DNA Technologies
• Illinois Institute of Technology
• Illumina
• Immatics Biotechnologies
• Intact Genomics
• Johns Hopkins University
• Leland Stanford Junior University
• Lexogen
• LGC
• Loop Genomics
• Lucigen (Acquired by LGC)
• Macrogen
• MagBio Genomics
• Maryland Genomics
• Massachusetts General Hospital
• Massachusetts Institute of Technology
• Massey University
• Mass General Brigham (Previously known as Partners HealthCare)
• Max Planck Institute
• McGill University
• Molecular Cloning Laboratories (MCLAB)
• MedGenome
• Merck
• MGI
• Microsynth
• MNG Laboratories (Acquired by LabCorp)
• MOgene
• myGenomics
• Natera
• National Institute of Health and Medical Research (INSERM)
• National Instrumentation Center for Environmental Management
• New England Biolabs (NEB)
• New York Genome Center (NYGC)
• NimaGen
• Norgen Biotek
• Novogene
• Nucleome Informatics
• OGT
• Oklahoma Medical Research Foundation (OMRF)
• Omega Bioservices
• Otogenetics
• Oxford Nanopore Technologies
• Pacific Biosciences (PacBio)
• PerkinElmer
• Phalanx Biotech
• Psomagen
• Q2 Solutions
• QIAGEN
• Quantabio
• Quick Biology
• Rapid Genomics
• RealSeq Biosciences
• REPROCELL
• Roche
• RTL Genomics
• SeqLL
• SeqMatic
• Shanghai Oe Biotech
• Source BioScience
• Stanford University
• StarSEQ
• Swift Biosciences (Acquired by IDT)
• System Biosciences (SBI)
• Takara Bio
• Tecan
• Tempus
• Texas A&M AgriLife
• The Sequencing Center
• Theragen Etex
• Thermo Fisher Scientific
• The University of Edinburgh
• TIANGEN Biotech
• TransGen Biotech
• TriLink BioTechnologies
• Twist Bioscience
• UCLA Health
• University of California
• University of Delaware
• University of Leeds
• University of Liverpool
• University of Maryland
• University of Minnesota
• University of Oxford
• University of Texas
• University of Washington
• University of Wisconsin
• University of Zurich
• UNSW Sydney
• Uppsala University
• Vazyme Biotech
• Veritas
• Verogen
• Waksman Institute of Microbiology (Rutgers University)
• Washington State University
• Washington University
• Wuhan Fraser Gene Information
• Xcelris Genomics
• Yaazh Xenomics
• Yale School of Medicine
• YouSeq
• Zymo Research

For more information about this report visit https://www.researchandmarkets.com/r/kmcr8x

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900